Expression Analysis of Long Non-Coding PCAT-1in Breast Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

1. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.Journal of cellular and molecular medicine · 2019
   Pooled it
2. Biological and Clinical Relevance of Long Non-Coding RNA PCAT-1 in Cancer, A Systematic Review and Meta-AnalysisAsian Pacific journal of cancer prevention : APJCP · 2019
   Pooled it
3. LncRNA PCAT-1 in gastrointestinal cancers: A meta-analysis.Medicine · 2018
   Pooled it
4. Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications.Clinical and experimental medicine · 2026
   Review
5. Epigenetic and Immunological Features of Bladder Cancer.International journal of molecular sciences · 2023
   Review
6. Screening potential lncRNA biomarkers for breast cancer and colorectal cancer combining random walk and logistic matrix factorization.Frontiers in genetics · 2022
   Article
7. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.Bioengineered · 2021
   Article
8. What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1).Non-coding RNA research · 2021
   Article
9. Functional roles of lncRNAs in the pathogenesis and progression of cancer.Genes & diseases · 2021
   Review
10. PCAT-1 facilitates breast cancer progression via binding to RACK1 and enhancing oxygen-independent stability of HIF-1α.Molecular therapy. Nucleic acids · 2021
    Article
11. 8q24.21 Locus: A Paradigm to Link Non-Coding RNAs, Genome Polymorphisms and Cancer.International journal of molecular sciences · 2021
    Review
12. IDSSIM: an lncRNA functional similarity calculation model based on an improved disease semantic similarity method.BMC bioinformatics · 2020
    Article
13. PCAT-1: A Novel Oncogenic Long Non-Coding RNA in Human Cancers.International journal of biological sciences · 2019
    Review
14. Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways.Journal of Cancer · 2019
    Article
15. Long non-coding RNA expression in bladder cancer.Biophysical reviews · 2018
    Review
16. Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues.Cancer management and research · 2018
    Article
17. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.Cancer biomarkers : section A of Disease markers · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as